A role for MAP kinase in differentiated smooth muscle contraction evoked by a-adrenoceptor stimulation

Dessy, Chantal, Inkyeom Kim, Carrie L. Sougnez, Regent Laporte, and Kathleen G. Morgan. A role for MAP kinase in differentiated smooth muscle contraction evoked by a-adrenoceptor stimulation. Am. J. Physiol. 275 (Cell Physiol. 44): C1081–C1086, 1998.—The purpose of this study was to investigate the potential role of mitogen-activated protein (MAP) kinase in smooth muscle contraction by monitoring MAP kinase activation, caldesmon phosphorylation, and contractile force during agonist stimulation. Isometric tension in response to KCl and phenylephrine (PE) was measured from strips of ferret aorta. MAP kinase activation was monitored by Western blot using a phosphospecific p44/p42 MAP kinase antibody. Caldesmon phosphorylation was assessed using specific phosphocaldesmon antibodies. We report here that treatment of smooth muscle strips with PD-098059, a specific inhibitor of MAP kinase kinase, did not detectably modify the KCl-evoked contraction but significantly inhibited the contraction to PE in the absence of extracellular Ca21. In this experimental condition, where the contraction occurs in the absence of increases in 20-kDa myosin light chain phosphorylation, PD-098059 also inhibited significantly MAP kinase and caldesmon phosphorylation. Collectively, these results demonstrate a direct cause-and-effect relationship between MAP kinase activation and Ca21-independent smooth muscle contraction and support the concept of caldesmon phosphorylation as the missing link between both events.